PanTracer LBx

In the evolving landscape of precision oncology, accessing tumor-specific genomic insights quickly and noninvasively is critical. PanTracer LBx is a liquid biopsy test that delivers comprehensive, clinically actionable insights from a simple blood draw. It empowers real-time decision-making, especially for patients for whom tissue biopsies are not feasible.

​ ​

• 514 genes, detecting both guideline-recommended and emerging alterations​
• High sensitivity, ctDNA sequencing for detection from blood samples​
• Minimally invasive CGP results, ideal for patients where tissue testing fails or when tissue is unavailable

COMING SOON